177 related articles for article (PubMed ID: 20196945)
1. [Drug resistance, genotype, and serotype of hepatitis B virus in nucleos(t)ide analogue naive patients with chronic hepatitis B].
Li XG; Xu J; Liu BM; Yang JX; Yan L; Li T; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):92-5. PubMed ID: 20196945
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
Li XG; Liu BM; Xu J; Liu XE; Ding H; Li T
J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
[TBL] [Abstract][Full Text] [Related]
3. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.
Sayan M; Sentürk O; Akhan SÇ; Hülagü S; Cekmen MB
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e136-41. PubMed ID: 20382061
[TBL] [Abstract][Full Text] [Related]
5. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
Reijnders JG; Perquin MJ; Zhang N; Hansen BE; Janssen HL
Gastroenterology; 2010 Aug; 139(2):491-8. PubMed ID: 20381492
[TBL] [Abstract][Full Text] [Related]
6. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC
Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
Sayan M; Akhan SC; Meric M
J Viral Hepat; 2010 Jan; 17(1):23-7. PubMed ID: 19566788
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.
Jardi R; Rodriguez-Frias F; Schaper M; Giggi E; Tabernero D; Homs M; Esteban R; Buti M
J Hepatol; 2008 Nov; 49(5):695-701. PubMed ID: 18490074
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
Jung SK; Kim KA; Ha SY; Lee HK; Kim YD; Lee BH; Paik WH; Kim JW; Bae WK; Kim NH; Lee JS; Jwa YJ
Clin Mol Hepatol; 2015 Mar; 21(1):41-8. PubMed ID: 25834801
[TBL] [Abstract][Full Text] [Related]
10. [Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].
Xu LJ; Pan C; Li QG; Chen RH; Zheng L; Zhang QY; Chen HC
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):180-3. PubMed ID: 20380793
[TBL] [Abstract][Full Text] [Related]
11. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.
Liu BM; Li T; Xu J; Li XG; Dong JP; Yan P; Yang JX; Yan L; Gao ZY; Li WP; Sun XW; Wang YH; Jiao XJ; Hou CS; Zhuang H
Antiviral Res; 2010 Mar; 85(3):512-9. PubMed ID: 20034521
[TBL] [Abstract][Full Text] [Related]
12. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Hongthanakorn C; Chotiyaputta W; Oberhelman K; Fontana RJ; Marrero JA; Licari T; Lok AS
Hepatology; 2011 Jun; 53(6):1854-63. PubMed ID: 21618260
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus resistance to nucleos(t)ide analogues.
Zoulim F; Locarnini S
Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
[TBL] [Abstract][Full Text] [Related]
14. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
[TBL] [Abstract][Full Text] [Related]
16. [The genetic variability and clinical significance of hepatitis B virus].
Tang H; Chen EQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):161-3. PubMed ID: 19554777
[No Abstract] [Full Text] [Related]
17. [Mutation analysis of the HBV reverse transcriptase in nucleos(t)ide-treated patients with chronic HBV infection].
Jiao XJ; Peng X; Jiao XM; Wang JS; Sun XW; Zhao PL; Wang SY; Liu JQ; Li T; Yang JX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):453-5. PubMed ID: 23627028
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.
Singla B; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
J Med Virol; 2013 Jul; 85(7):1155-62. PubMed ID: 23918533
[TBL] [Abstract][Full Text] [Related]
19. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
